Dover, MA, United States of America

Michele Picard

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Momenta Pharmaceuticals, Inc.. Active years: 2009.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michele Picard: Innovator in Pulmonary Delivery Systems

Introduction

Michele Picard is a notable inventor based in Dover, MA (US). She has made significant contributions to the field of pharmaceutical sciences, particularly in the area of pulmonary delivery systems. Her innovative work focuses on enhancing the effectiveness of therapeutic agents through advanced formulations.

Latest Patents

Michele holds a patent for "Polysaccharides for pulmonary delivery of active agents." This patent describes a formulation designed for the pulmonary delivery of therapeutic, prophylactic, or diagnostic agents, which includes a low molecular weight heparin. This innovative approach aims to improve the delivery and efficacy of various medical treatments.

Career Highlights

Michele Picard is currently associated with Momenta Pharmaceuticals, Inc., where she continues to advance her research and development efforts. Her work has been instrumental in creating new solutions for drug delivery, particularly in the pulmonary sector.

Collaborations

Michele has collaborated with esteemed colleagues such as Thomas Richardson and Ganesh Venkataraman. These partnerships have fostered a collaborative environment that enhances innovation and drives research forward.

Conclusion

Michele Picard's contributions to the field of pulmonary delivery systems exemplify her dedication to improving healthcare through innovative solutions. Her patent and ongoing work at Momenta Pharmaceuticals, Inc. highlight her role as a leading inventor in this critical area of research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…